Gibson Christopher bought RXRX
February 6, 2026 · Form 4 insider transaction
Gibson Christopher bought 30,346 shares of Recursion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,346
Price
$0.00
Total value
N/A
InsiderGibson Christopher
Role—
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateFebruary 6, 2026
Filing dateFebruary 6, 2026
Shares owned after944,185
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This RSU vested immediately upon the grant date.